| Title : Early development of symptomatic drugs in AD: a systematic review of the use of biomarkers - Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_ |
| Author(s) : Deguil J , Ravasi L , Lamberty Y , Auffret A , Payoux P , Leroy C , Derambure P , Bordet R |
| Ref : CNS Neurol Disord Drug Targets , : , 2016 |
| Abstract : Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_ |
| ESTHER : Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_ |
| PubMedSearch : Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_ |
| PubMedID: 27189465 |
Deguil J, Ravasi L, Lamberty Y, Auffret A, Payoux P, Leroy C, Derambure P, Bordet R (2016)
Early development of symptomatic drugs in AD: a systematic review of the use of biomarkers
CNS Neurol Disord Drug Targets
:
Deguil J, Ravasi L, Lamberty Y, Auffret A, Payoux P, Leroy C, Derambure P, Bordet R (2016)
CNS Neurol Disord Drug Targets
: